Genlong Xue Selected Research

Genlong Xue Research Topics

3	Heart Failure 01/2023 - 01/2022
3	Cardiac Arrhythmias (Arrythmia) 01/2023 - 01/2022
2	Atrial Fibrillation 05/2024 - 08/2019
2	Myocardial Infarction 01/2022 - 01/2022
2	Reperfusion Injury 01/2022 - 01/2021
2	Hypertrophy 01/2022 - 01/2022
1	Muscular Dystrophies (Muscular Dystrophy) 01/2023
1	Atrial Remodeling 01/2022
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Cardiomegaly (Heart Hypertrophy) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Ischemia 01/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2020

2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2022
2	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2022
2	Long Noncoding RNAIBA 01/2022 - 01/2021
1	Type 2 Galanin ReceptorIBA 05/2024
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2024
1	DystrophinIBA 01/2023
1	empagliflozinIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	CalcineurinIBA 01/2022
1	Cullin Proteins (Cullins)IBA 01/2022
1	fibroblast growth factor 21IBA 01/2020
1	Therapeutic UsesIBA 08/2019
1	6- (4- (trifluoromethoxy)phenyl)- 3- (trifluoromethyl)(1,2,4)triazolo(4,3- a)pyridineIBA 08/2019
1	SodiumIBA 08/2019